Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
bristol-myers squibb
clinical trials
celgene
deals
johnson & johnson
pfizer
abbvie
aducanumab
biogen
eli lilly
fda
gene therapy
genentech
What
bio
7
×
news
7
×
roundup
drug
fda
nash
approved
biogen
biogen’s
companies
drugs
help
medical
new
road
week
accelerating
adu
aducanumab
alleviate
alzheimer’s
amyloid
angst
approval
area
aren’t
august
bagged
beats
bids
billions
biopharmaceutical
biotech
bounds
brammer
busy
cells
clearly
complicated
conditions
Language
unset
Current search:
bio
×
news
×
@techcrunch.com
1 month ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
